Author:
Neri Luca, ,Conway Paul Maurice,Basilisco Guido
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference26 articles.
1. Spiegel, B., Camilleri, M., Bolus, R., Andresen, V., Chey, W. D., Fehnel, S., et al. (2009). Psychometric evaluation of patient-reported outcomes in irritable bowel syndrome randomized controlled trials: A Rome Foundation report. Gastroenterology, 137(6), 1944–1953.
2. Frank, L., Kleinman, L., Farup, C., Taylor, L., & Miner, P, Jr. (1999). Psychometric validation of a constipation symptom assessment questionnaire. Scandinavian Journal of Gastroenterology, 348, 70–77.
3. Tack, J., Stanghellini, V., Dubois, D., Joseph, A., Vandeplassche, L., & Kerstens, R. (2014). Effect of prucalopride on symptoms of chronic constipation. Neurogastroenterology and Motility, 1, 21–27.
4. Camilleri, M., Kerstens, R., Rykx, A., et al. (2008). A placebo-controlled trial of prucalopride for severe chronic constipation. New England Journal of Medicine, 358, 2344–2354.
5. Quigley, E. M., Vandeplassche, L., Kerstens, R., & Ausma, J. (2009). Clinical trial: The efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation—A 12-week, randomized, double-blind, placebo-controlled study. Alimentary Pharmacology and Therapeutics, 29, 315–328.
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献